Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (4341)	4/13/2000 9:44:00 AM
From: RCMac	Read Replies (1) of 10280

>>The importance isn't isolated to r-prozac, it's critical to the company's business plan as about half of their patented candidates are earmarked as "life cycle management" drugs, i.e. license back to innovator. This should help clear the way for new deals.<< Sepracor management agrees. The CFO was quoted on the Yahoo SEPR club this AM as saying that "the company can now proceed . . . with several other deals": "David Southwell called me this morning . . . to give me the news that is now known to everyone... he was ecstatic, stating that the company can now proceed with not only the LLY deal but with several other deals that have been delayed waiting on the decision.."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next